Obstructive Sleep Apnea Patients Should Be Monitored for Erectile Dysfunction

Written by Mohan Garikiparithi
Published on

Obstructive sleep apnea patientsObstructive sleep apnea is the periodic cessation of breathing during sleep, cutting off oxygen to the brain and lungs. It’s a relatively common chronic condition that is believed to affect 10 percent of middle-aged men. The condition can be asymptomatic but often results in poorer sleep quality, sleepiness during the daytime, and lowered quality of life. Past research has connected sleep apnea with cardiovascular disease, stroke, and hypertension, but new research has found that there may also be a connection between sleep apnea and erectile dysfunction in men.

Erectile dysfunction is the inability to achieve and maintain an erection to sexual satisfaction. It is not uncommon, affecting around 20 percent of men between the ages of 30 and 70, with prevalence rising with age. There has also been a connection shown between the prevalence of erectile dysfunction and sleep apnea, with 69 percent of male sleep apnea patients complaining of erectile problems as well. These patients are also considered to be at an increased risk for cardiovascular disease.

The researchers behind the current study chose to examine erectile dysfunction in newly diagnosed sleep apnea patients to gather further information on the topic. They wanted to compare the hormonal, psychological, and biological profiles of sleep apnea patients with and without erectile dysfunction. Finally, they wanted to assess whether continuous positive airway pressure (CPAP) treatment could successfully treat erectile dysfunction in sleep apnea patients.

The participants included 150 male patients, aged 18 to 70, with newly diagnosed sleep apnea ranging from moderate to severe. They found a prevalence of 51 percent for erectile dysfunction. They noted that the patients with erectile dysfunction tended to be older, had higher waist to hip ratios, had higher glucose levels, and were more frequently undergoing pharmacological treatment than the patients without erectile dysfunction.

CPAP Treatment Increases Sexual Satisfaction

The patients with erectile dysfunction were then sub-divided into an experimental group and a control group. The experimental group underwent three months of CPAP treatment, while the control group did not. After the three-month period, erectile dysfunction, sexual satisfaction, and overall satisfaction had improved in the CPAP group.

Only changes in the sexual satisfaction of those in the experimental group were statistically significant over those in the control group, however. The treatment did not show any changes to the psychological, hormonal, or biochemical profiles of the patients with erectile dysfunction.

The results of this study are concurrent with the canon of literature on erectile dysfunction in patients with obstructive sleep apnea. The prevalence of erectile dysfunction found here was slightly lower than normal (51 percent versus 69 percent), but the researchers feel this is due to their use of harsher exclusion criteria, having omitted from the study any participants who had significant risk factors for erectile dysfunction.

These results are statistically significant and suggest that male patients who are diagnosed with erectile dysfunction should also be tested for sleep apnea, as there is a proven link between them. CPAP treatment may then also help to increase their sexual satisfaction if that is the case.

Also read:


Related Reading:

Advertisement

On any matter relating to your health or well-being, please check with an appropriate health professional. No statement herein is to be construed as a diagnosis, treatment, preventative, or cure for any disease, disorder or abnormal physical state. The statements herein have not been evaluated by the Foods and Drugs Administration or Health Canada. Dr. Marchione and the doctors on the Bel Marra Health Editorial Team are compensated by Bel Marra Health for their work in creating content, consulting along with formulating and endorsing products.

Exit mobile version